輸入代號或公司名稱後按 Enter
4123

晟德

-0.10 (-0.33%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
30.251,051成交張數22.74本益比1.33股價淨值比7.42%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-13.201.26-104.47-2417.9%-45.92%6.00%
2026Q12.50262.2%13.5519.66421.8%7.17%45.73%
2025Q48.3911.7467.831697.7%29.41%41.86%
2025Q33.58887.1%2.3827.18756.8%14.92%9.13%
2025Q2-0.92-0.83-7.27-191.8%-4.10%-3.75%
2025Q10.69-0.015.49144.9%2.99%-0.07%
2024Q4-0.97-1.41-7.64-170.2%-4.09%-5.84%
2024Q30.36-0.532.7369.6%1.44%-2.19%
2024Q2-0.09-2.24-0.72-17.5%-0.38%-8.76%
2024Q1-0.71-151.3%-3.44-5.41-148.9%-2.77%-12.81%
2023Q4-0.09-649.7%-1.36-0.75-18.6%-0.39%-5.10%
2023Q3-1.35-1.25-9.79-286.9%-5.16%-4.78%
2023Q2-1.29-1.45-9.33-298.8%-4.72%-5.29%
2023Q11.38-28.8%-0.429.92296.0%5.03%-1.30%
2022Q40.020.140.187.4%0.09%0.54%
2022Q3-1.55-0.89-10.94-634.8%-5.70%-3.21%
2022Q2-0.26-114.9%-0.50-1.80-87.9%-0.90%-1.70%
2022Q11.94-36.1%1.5013.59893.9%6.87%5.20%
2021Q4-1.01-151.2%2.59-7.08-583.6%-3.67%9.84%
2021Q3-1.17-191.8%5.59-8.13-925.6%-3.98%21.54%
2021Q21.74-12.6%8.0212.19919.8%5.91%31.69%
2021Q13.03851.0%8.2721.181337.4%11.14%33.80%
2020Q41.985.5613.74799.0%7.96%24.23%
2020Q31.272660.0%3.379.48720.5%6.10%15.85%
2020Q21.993235.8%2.1412.551196.5%8.91%10.10%
2020Q10.320.212.1068.0%1.56%1.04%
2019Q4-0.21-103.4%-0.44-1.37-36.3%-1.08%-2.17%
2019Q30.05-98.2%6.030.308.6%0.24%36.32%
2019Q20.06-77.8%8.490.3510.1%0.28%55.82%
2019Q1-0.34-146.1%8.70-2.14-59.5%-1.65%53.46%
2018Q46.261490.3%9.7739.18148.9%36.20%61.24%
2018Q32.502805.5%3.9015.8226.3%20.68%31.76%
2018Q20.271.481.371.9%1.93%13.09%
2018Q10.731.174.477.6%6.27%10.22%
2017Q40.390.412.414.1%3.60%3.68%
2017Q30.09-75.0%-0.110.511.0%0.77%-0.92%
2017Q2-0.040.15-0.21-0.4%-0.31%1.32%
2017Q1-0.030.10-0.21-0.5%-0.31%0.87%
2016Q4-0.120.03-0.73-1.6%-1.03%
2016Q30.342.055.8%2.85%